Williams IS, Perera S, Murphy DG, Corcoran NM, et al. Active surveillance versus enzalutamide for low-risk prostate cancer- was it really a trial we needed? BJU Int 2022 Jul 25. doi: 10.1111/bju.15860.
PMID: 35879832